Crossmark

Process optimization and particle engineering of micronized drug powders via milling

Crossref DOI link: https://doi.org/10.1007/s13346-017-0444-x

Published Online: 2017-11-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brunaugh, A.

Smyth, H. D. C.
License Information

Text and Data Mining valid from 2017-11-13
More Information

Article History

First Online: 13 November 2017

Compliance with ethical standards

:

: The author (HDCS) of this paper consults for and has equity ownership in Respira Therapeutics and Nob Hill Therapeutics on inhaled product development. The terms of this arrangement have been reviewed and approved by the University of Texas at Austin in accordance with its policy on objectivity in research.